This report aims to provide a comprehensive presentation of the global market for Multivalent Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multivalent Vaccines. This report contains market size and forecasts of Multivalent Vaccines in global, including the following market information:
Global Multivalent Vaccines Market Revenue, 2018-2023, 20242035, ($ millions)
Global Multivalent Vaccines Market Sales, 2018-2023, 20242035, (K Pcs)
Global top five Multivalent Vaccines companies in 2022 (%)
The global Multivalent Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Conjugate Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multivalent Vaccines include GlaxoSmithKline, plc (U.K.), Pfizer, Inc (US), Merck & Co., Inc (US), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc (US), Johnson & Johnson (US) and MedImmune, LLC (US), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Multivalent Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multivalent Vaccines Market, by Type, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, by Type, 2022 (%)
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Global Multivalent Vaccines Market, by Application, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, by Application, 2022 (%)
Pediatrics
Adults
Global Multivalent Vaccines Market, By Region and Country, 2018-2023, 20242035 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multivalent Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Multivalent Vaccines revenues share in global market, 2022 (%)
Key companies Multivalent Vaccines sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Multivalent Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline, plc (U.K.)
Pfizer, Inc (US)
Merck & Co., Inc (US)
Sanofi Pasteur SA (France)
Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions, Inc (US)
Johnson & Johnson (US)
MedImmune, LLC (US)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo (Japan)
Protein Sciences Corporation (US)
Panacea Biotec (India)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multivalent Vaccines, market overview.
Chapter 2: Global Multivalent Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Multivalent Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multivalent Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Multivalent Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Multivalent Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multivalent Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multivalent Vaccines Overall Market Size
2.1 Global Multivalent Vaccines Market Size: 2022 VS 2035
2.2 Global Multivalent Vaccines Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Multivalent Vaccines Sales: 2018-2035
3 Company Landscape
3.1 Top Multivalent Vaccines Players in Global Market
3.2 Top Global Multivalent Vaccines Companies Ranked by Revenue
3.3 Global Multivalent Vaccines Revenue by Companies
3.4 Global Multivalent Vaccines Sales by Companies
3.5 Global Multivalent Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Multivalent Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Multivalent Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multivalent Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Multivalent Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Multivalent Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Multivalent Vaccines Market Size Markets, 2022 & 2035
4.1.2 Conjugate Vaccines
4.1.3 Inactivated and Subunit Vaccines
4.1.4 Live Attenuated Vaccines
4.1.5 Toxoid Vaccines
4.1.6 Recombinant Vaccines
4.2 By Type - Global Multivalent Vaccines Revenue & Forecasts
4.2.1 By Type - Global Multivalent Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Multivalent Vaccines Revenue, 2024-2035
4.2.3 By Type - Global Multivalent Vaccines Revenue Market Share, 2018-2035
4.3 By Type - Global Multivalent Vaccines Sales & Forecasts
4.3.1 By Type - Global Multivalent Vaccines Sales, 2018-2023
4.3.2 By Type - Global Multivalent Vaccines Sales, 2024-2035
4.3.3 By Type - Global Multivalent Vaccines Sales Market Share, 2018-2035
4.4 By Type - Global Multivalent Vaccines Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multivalent Vaccines Market Size, 2022 & 2035
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Multivalent Vaccines Revenue & Forecasts
5.2.1 By Application - Global Multivalent Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Multivalent Vaccines Revenue, 2024-2035
5.2.3 By Application - Global Multivalent Vaccines Revenue Market Share, 2018-2035
5.3 By Application - Global Multivalent Vaccines Sales & Forecasts
5.3.1 By Application - Global Multivalent Vaccines Sales, 2018-2023
5.3.2 By Application - Global Multivalent Vaccines Sales, 2024-2035
5.3.3 By Application - Global Multivalent Vaccines Sales Market Share, 2018-2035
5.4 By Application - Global Multivalent Vaccines Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Multivalent Vaccines Market Size, 2022 & 2035
6.2 By Region - Global Multivalent Vaccines Revenue & Forecasts
6.2.1 By Region - Global Multivalent Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Multivalent Vaccines Revenue, 2024-2035
6.2.3 By Region - Global Multivalent Vaccines Revenue Market Share, 2018-2035
6.3 By Region - Global Multivalent Vaccines Sales & Forecasts
6.3.1 By Region - Global Multivalent Vaccines Sales, 2018-2023
6.3.2 By Region - Global Multivalent Vaccines Sales, 2024-2035
6.3.3 By Region - Global Multivalent Vaccines Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Multivalent Vaccines Revenue, 2018-2035
6.4.2 By Country - North America Multivalent Vaccines Sales, 2018-2035
6.4.3 US Multivalent Vaccines Market Size, 2018-2035
6.4.4 Canada Multivalent Vaccines Market Size, 2018-2035
6.4.5 Mexico Multivalent Vaccines Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Multivalent Vaccines Revenue, 2018-2035
6.5.2 By Country - Europe Multivalent Vaccines Sales, 2018-2035
6.5.3 Germany Multivalent Vaccines Market Size, 2018-2035
6.5.4 France Multivalent Vaccines Market Size, 2018-2035
6.5.5 U.K. Multivalent Vaccines Market Size, 2018-2035
6.5.6 Italy Multivalent Vaccines Market Size, 2018-2035
6.5.7 Russia Multivalent Vaccines Market Size, 2018-2035
6.5.8 Nordic Countries Multivalent Vaccines Market Size, 2018-2035
6.5.9 Benelux Multivalent Vaccines Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Multivalent Vaccines Revenue, 2018-2035
6.6.2 By Region - Asia Multivalent Vaccines Sales, 2018-2035
6.6.3 China Multivalent Vaccines Market Size, 2018-2035
6.6.4 Japan Multivalent Vaccines Market Size, 2018-2035
6.6.5 South Korea Multivalent Vaccines Market Size, 2018-2035
6.6.6 Southeast Asia Multivalent Vaccines Market Size, 2018-2035
6.6.7 India Multivalent Vaccines Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Multivalent Vaccines Revenue, 2018-2035
6.7.2 By Country - South America Multivalent Vaccines Sales, 2018-2035
6.7.3 Brazil Multivalent Vaccines Market Size, 2018-2035
6.7.4 Argentina Multivalent Vaccines Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Multivalent Vaccines Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Multivalent Vaccines Sales, 2018-2035
6.8.3 Turkey Multivalent Vaccines Market Size, 2018-2035
6.8.4 Israel Multivalent Vaccines Market Size, 2018-2035
6.8.5 Saudi Arabia Multivalent Vaccines Market Size, 2018-2035
6.8.6 UAE Multivalent Vaccines Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline, plc (U.K.)
7.1.1 GlaxoSmithKline, plc (U.K.) Company Summary
7.1.2 GlaxoSmithKline, plc (U.K.) Business Overview
7.1.3 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline, plc (U.K.) Key News & Latest Developments
7.2 Pfizer, Inc (US)
7.2.1 Pfizer, Inc (US) Company Summary
7.2.2 Pfizer, Inc (US) Business Overview
7.2.3 Pfizer, Inc (US) Multivalent Vaccines Major Product Offerings
7.2.4 Pfizer, Inc (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer, Inc (US) Key News & Latest Developments
7.3 Merck & Co., Inc (US)
7.3.1 Merck & Co., Inc (US) Company Summary
7.3.2 Merck & Co., Inc (US) Business Overview
7.3.3 Merck & Co., Inc (US) Multivalent Vaccines Major Product Offerings
7.3.4 Merck & Co., Inc (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co., Inc (US) Key News & Latest Developments
7.4 Sanofi Pasteur SA (France)
7.4.1 Sanofi Pasteur SA (France) Company Summary
7.4.2 Sanofi Pasteur SA (France) Business Overview
7.4.3 Sanofi Pasteur SA (France) Multivalent Vaccines Major Product Offerings
7.4.4 Sanofi Pasteur SA (France) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur SA (France) Key News & Latest Developments
7.5 Astellas Pharma Inc. (Japan)
7.5.1 Astellas Pharma Inc. (Japan) Company Summary
7.5.2 Astellas Pharma Inc. (Japan) Business Overview
7.5.3 Astellas Pharma Inc. (Japan) Multivalent Vaccines Major Product Offerings
7.5.4 Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Astellas Pharma Inc. (Japan) Key News & Latest Developments
7.6 CSL Limited (Australia)
7.6.1 CSL Limited (Australia) Company Summary
7.6.2 CSL Limited (Australia) Business Overview
7.6.3 CSL Limited (Australia) Multivalent Vaccines Major Product Offerings
7.6.4 CSL Limited (Australia) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 CSL Limited (Australia) Key News & Latest Developments
7.7 Emergent BioSolutions, Inc (US)
7.7.1 Emergent BioSolutions, Inc (US) Company Summary
7.7.2 Emergent BioSolutions, Inc (US) Business Overview
7.7.3 Emergent BioSolutions, Inc (US) Multivalent Vaccines Major Product Offerings
7.7.4 Emergent BioSolutions, Inc (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Emergent BioSolutions, Inc (US) Key News & Latest Developments
7.8 Johnson & Johnson (US)
7.8.1 Johnson & Johnson (US) Company Summary
7.8.2 Johnson & Johnson (US) Business Overview
7.8.3 Johnson & Johnson (US) Multivalent Vaccines Major Product Offerings
7.8.4 Johnson & Johnson (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson (US) Key News & Latest Developments
7.9 MedImmune, LLC (US)
7.9.1 MedImmune, LLC (US) Company Summary
7.9.2 MedImmune, LLC (US) Business Overview
7.9.3 MedImmune, LLC (US) Multivalent Vaccines Major Product Offerings
7.9.4 MedImmune, LLC (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 MedImmune, LLC (US) Key News & Latest Developments
7.10 Serum Institute of India Pvt. Ltd. (India)
7.10.1 Serum Institute of India Pvt. Ltd. (India) Company Summary
7.10.2 Serum Institute of India Pvt. Ltd. (India) Business Overview
7.10.3 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Major Product Offerings
7.10.4 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Serum Institute of India Pvt. Ltd. (India) Key News & Latest Developments
7.11 Bavarian Nordic (Denmark)
7.11.1 Bavarian Nordic (Denmark) Company Summary
7.11.2 Bavarian Nordic (Denmark) Multivalent Vaccines Business Overview
7.11.3 Bavarian Nordic (Denmark) Multivalent Vaccines Major Product Offerings
7.11.4 Bavarian Nordic (Denmark) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Bavarian Nordic (Denmark) Key News & Latest Developments
7.12 Mitsubishi Tanabe Pharma Corporation (Japan)
7.12.1 Mitsubishi Tanabe Pharma Corporation (Japan) Company Summary
7.12.2 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Business Overview
7.12.3 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Major Product Offerings
7.12.4 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Mitsubishi Tanabe Pharma Corporation (Japan) Key News & Latest Developments
7.13 Daiichi Sankyo (Japan)
7.13.1 Daiichi Sankyo (Japan) Company Summary
7.13.2 Daiichi Sankyo (Japan) Multivalent Vaccines Business Overview
7.13.3 Daiichi Sankyo (Japan) Multivalent Vaccines Major Product Offerings
7.13.4 Daiichi Sankyo (Japan) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Daiichi Sankyo (Japan) Key News & Latest Developments
7.14 Protein Sciences Corporation (US)
7.14.1 Protein Sciences Corporation (US) Company Summary
7.14.2 Protein Sciences Corporation (US) Business Overview
7.14.3 Protein Sciences Corporation (US) Multivalent Vaccines Major Product Offerings
7.14.4 Protein Sciences Corporation (US) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 Protein Sciences Corporation (US) Key News & Latest Developments
7.15 Panacea Biotec (India)
7.15.1 Panacea Biotec (India) Company Summary
7.15.2 Panacea Biotec (India) Business Overview
7.15.3 Panacea Biotec (India) Multivalent Vaccines Major Product Offerings
7.15.4 Panacea Biotec (India) Multivalent Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Panacea Biotec (India) Key News & Latest Developments
8 Global Multivalent Vaccines Production Capacity, Analysis
8.1 Global Multivalent Vaccines Production Capacity, 2018-2035
8.2 Multivalent Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Multivalent Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multivalent Vaccines Supply Chain Analysis
10.1 Multivalent Vaccines Industry Value Chain
10.2 Multivalent Vaccines Upstream Market
10.3 Multivalent Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multivalent Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Multivalent Vaccines in Global Market
Table 2. Top Multivalent Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Multivalent Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Multivalent Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Multivalent Vaccines Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Multivalent Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Multivalent Vaccines Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Multivalent Vaccines Product Type
Table 9. List of Global Tier 1 Multivalent Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multivalent Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Multivalent Vaccines Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Multivalent Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Multivalent Vaccines Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Multivalent Vaccines Sales (K Pcs), 2018-2023
Table 15. By Type - Global Multivalent Vaccines Sales (K Pcs), 2024-2035
Table 16. By Application ? Global Multivalent Vaccines Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Multivalent Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Multivalent Vaccines Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Multivalent Vaccines Sales (K Pcs), 2018-2023
Table 20. By Application - Global Multivalent Vaccines Sales (K Pcs), 2024-2035
Table 21. By Region ? Global Multivalent Vaccines Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Multivalent Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Multivalent Vaccines Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Multivalent Vaccines Sales (K Pcs), 2018-2023
Table 25. By Region - Global Multivalent Vaccines Sales (K Pcs), 2024-2035
Table 26. By Country - North America Multivalent Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Multivalent Vaccines Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Multivalent Vaccines Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Multivalent Vaccines Sales, (K Pcs), 2024-2035
Table 30. By Country - Europe Multivalent Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Multivalent Vaccines Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Multivalent Vaccines Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Multivalent Vaccines Sales, (K Pcs), 2024-2035
Table 34. By Region - Asia Multivalent Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Multivalent Vaccines Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Multivalent Vaccines Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Multivalent Vaccines Sales, (K Pcs), 2024-2035
Table 38. By Country - South America Multivalent Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Multivalent Vaccines Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Multivalent Vaccines Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Multivalent Vaccines Sales, (K Pcs), 2024-2035
Table 42. By Country - Middle East & Africa Multivalent Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Multivalent Vaccines Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Multivalent Vaccines Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Multivalent Vaccines Sales, (K Pcs), 2024-2035
Table 46. GlaxoSmithKline, plc (U.K.) Company Summary
Table 47. GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Product Offerings
Table 48. GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. GlaxoSmithKline, plc (U.K.) Key News & Latest Developments
Table 50. Pfizer, Inc (US) Company Summary
Table 51. Pfizer, Inc (US) Multivalent Vaccines Product Offerings
Table 52. Pfizer, Inc (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Pfizer, Inc (US) Key News & Latest Developments
Table 54. Merck & Co., Inc (US) Company Summary
Table 55. Merck & Co., Inc (US) Multivalent Vaccines Product Offerings
Table 56. Merck & Co., Inc (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Merck & Co., Inc (US) Key News & Latest Developments
Table 58. Sanofi Pasteur SA (France) Company Summary
Table 59. Sanofi Pasteur SA (France) Multivalent Vaccines Product Offerings
Table 60. Sanofi Pasteur SA (France) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Sanofi Pasteur SA (France) Key News & Latest Developments
Table 62. Astellas Pharma Inc. (Japan) Company Summary
Table 63. Astellas Pharma Inc. (Japan) Multivalent Vaccines Product Offerings
Table 64. Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Astellas Pharma Inc. (Japan) Key News & Latest Developments
Table 66. CSL Limited (Australia) Company Summary
Table 67. CSL Limited (Australia) Multivalent Vaccines Product Offerings
Table 68. CSL Limited (Australia) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. CSL Limited (Australia) Key News & Latest Developments
Table 70. Emergent BioSolutions, Inc (US) Company Summary
Table 71. Emergent BioSolutions, Inc (US) Multivalent Vaccines Product Offerings
Table 72. Emergent BioSolutions, Inc (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Emergent BioSolutions, Inc (US) Key News & Latest Developments
Table 74. Johnson & Johnson (US) Company Summary
Table 75. Johnson & Johnson (US) Multivalent Vaccines Product Offerings
Table 76. Johnson & Johnson (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Johnson & Johnson (US) Key News & Latest Developments
Table 78. MedImmune, LLC (US) Company Summary
Table 79. MedImmune, LLC (US) Multivalent Vaccines Product Offerings
Table 80. MedImmune, LLC (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. MedImmune, LLC (US) Key News & Latest Developments
Table 82. Serum Institute of India Pvt. Ltd. (India) Company Summary
Table 83. Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Product Offerings
Table 84. Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Serum Institute of India Pvt. Ltd. (India) Key News & Latest Developments
Table 86. Bavarian Nordic (Denmark) Company Summary
Table 87. Bavarian Nordic (Denmark) Multivalent Vaccines Product Offerings
Table 88. Bavarian Nordic (Denmark) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Bavarian Nordic (Denmark) Key News & Latest Developments
Table 90. Mitsubishi Tanabe Pharma Corporation (Japan) Company Summary
Table 91. Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Product Offerings
Table 92. Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Mitsubishi Tanabe Pharma Corporation (Japan) Key News & Latest Developments
Table 94. Daiichi Sankyo (Japan) Company Summary
Table 95. Daiichi Sankyo (Japan) Multivalent Vaccines Product Offerings
Table 96. Daiichi Sankyo (Japan) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Daiichi Sankyo (Japan) Key News & Latest Developments
Table 98. Protein Sciences Corporation (US) Company Summary
Table 99. Protein Sciences Corporation (US) Multivalent Vaccines Product Offerings
Table 100. Protein Sciences Corporation (US) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Protein Sciences Corporation (US) Key News & Latest Developments
Table 102. Panacea Biotec (India) Company Summary
Table 103. Panacea Biotec (India) Multivalent Vaccines Product Offerings
Table 104. Panacea Biotec (India) Multivalent Vaccines Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Panacea Biotec (India) Key News & Latest Developments
Table 106. Multivalent Vaccines Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 107. Global Multivalent Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Multivalent Vaccines Production by Region, 2018-2023 (K Pcs)
Table 109. Global Multivalent Vaccines Production by Region, 2024-2035 (K Pcs)
Table 110. Multivalent Vaccines Market Opportunities & Trends in Global Market
Table 111. Multivalent Vaccines Market Drivers in Global Market
Table 112. Multivalent Vaccines Market Restraints in Global Market
Table 113. Multivalent Vaccines Raw Materials
Table 114. Multivalent Vaccines Raw Materials Suppliers in Global Market
Table 115. Typical Multivalent Vaccines Downstream
Table 116. Multivalent Vaccines Downstream Clients in Global Market
Table 117. Multivalent Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Multivalent Vaccines Segment by Type in 2022
Figure 2. Multivalent Vaccines Segment by Application in 2022
Figure 3. Global Multivalent Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Multivalent Vaccines Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Multivalent Vaccines Revenue, 2018-2035 (US$, Mn)
Figure 7. Multivalent Vaccines Sales in Global Market: 2018-2035 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Multivalent Vaccines Revenue in 2022
Figure 9. By Type - Global Multivalent Vaccines Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 11. By Type - Global Multivalent Vaccines Sales Market Share, 2018-2035
Figure 12. By Type - Global Multivalent Vaccines Price (USD/Pcs), 2018-2035
Figure 13. By Application - Global Multivalent Vaccines Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 15. By Application - Global Multivalent Vaccines Sales Market Share, 2018-2035
Figure 16. By Application - Global Multivalent Vaccines Price (USD/Pcs), 2018-2035
Figure 17. By Region - Global Multivalent Vaccines Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Multivalent Vaccines Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 20. By Region - Global Multivalent Vaccines Sales Market Share, 2018-2035
Figure 21. By Country - North America Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 22. By Country - North America Multivalent Vaccines Sales Market Share, 2018-2035
Figure 23. US Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Multivalent Vaccines Sales Market Share, 2018-2035
Figure 28. Germany Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 29. France Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Multivalent Vaccines Sales Market Share, 2018-2035
Figure 37. China Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 41. India Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 43. By Country - South America Multivalent Vaccines Sales Market Share, 2018-2035
Figure 44. Brazil Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Multivalent Vaccines Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Multivalent Vaccines Sales Market Share, 2018-2035
Figure 48. Turkey Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Multivalent Vaccines Revenue, (US$, Mn), 2018-2035
Figure 52. Global Multivalent Vaccines Production Capacity (K Pcs), 2018-2035
Figure 53. The Percentage of Production Multivalent Vaccines by Region, 2022 VS 2035
Figure 54. Multivalent Vaccines Industry Value Chain
Figure 55. Marketing Channels
